Page 3 - Best Myeloma doctors: TOP 73 doctors

Prof. Dr. Atilla Ozkan is a leading hematology expert specializing in myeloma treatment, with extensive experience in stem cell transplantation and apheresis.

• Over 23 years of experience of experience in hematology and internal medicine
• Current President of Turkish Therapeutic Apheresis Association
• Specializes in autologous and allogeneic stem cell transplantation
• Certified by EBMT for stem cell transplantation courses
• Professor at Yeditepe University Faculty of Medicine

Dr. Weidmann heads the Hematology sector at Nordwest Clinic with 36 years of experience specializing in blood disorders, including myeloma.

• 1,100+ procedures performed
• Specializes in Non-Hodgkin lymphoma treatment
• Professor with extensive academic background

Dr. Alemdar specializes in myeloma treatment with extensive training in medical oncology at Akdeniz University.

• Board-certified in medical oncology since 2018
• Over 20 years of experience of experience in internal medicine and oncology
• Worked at Akdeniz University Hospital, a leading medical institution
• Member of the Turkish Medical Oncology Association

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Oncohematologist Ofer Spielberg treats blood cancers at Assuta Medical Center.

• Specializes exclusively in treating myeloma and other blood disorders
• Works within a major Israeli hospital network known for advanced oncology

Professor Ben-Yehuda is Head of Hematology at Hadassah Medical Center and a recognized Dean of its Medical School.

• Over 34 years of experience of experience treating malignant blood diseases including myeloma
• Trained at the prestigious Memorial Sloan-Kettering Cancer Center in New York
• Specializes in bone marrow transplantation and advanced gene therapy
• Leads research in molecular diagnostics for hematological diseases
• Holder of the Healing with the Heart Award for exceptional patient care

Prof. Bosch leads 80+ clinical trials for myeloma and leukemia, pioneering new treatments at Quironsalud Barcelona. His research shapes future therapies worldwide.

• Head of Hematology at IOB Institute of Oncology since 2004
• Published 100+ studies in journals like The New England Journal of Medicine
• President of Spain's chronic lymphocytic leukemia research group (GELLC)
• Trained at Columbia University's Institute of Cancer Genetics

Prof. Serdar Bedii Omay has published 65+ scientific articles on hematology and bone marrow transplantation, with extensive research experience.

• Trained at Japan's Mie Medical Faculty in molecular hematology
• Professor of hematology at multiple Turkish universities
• Specializes in both clinical hematology and advanced research
• Former assistant professor at Ege University's hematology department

Associate Professor in Hematology with 50+ publications—Dr. Eren specializes in Myeloma at Biruni University Hospital.

• Completed advanced training at Istanbul Training and Research Hospital
• Member of European Society of Hematology and Turkish Hematology Association
• Recipient of multiple awards for hematologic research
• Fluent in English for international patient consultations

Dr. Apak has 26 years of experience leading the Pediatric Hematology-Oncology Division at Istanbul University-Cerrahpaşa – one of Turkey's top medical institutions.

• Specializes in bone marrow transplants and CAR T-cell therapy for pediatric cases
• Published 75 international papers on pediatric oncology treatments
• Former editor for Turkish Pediatrics Archives – ensures evidence-based care
• Currently heads pediatric hematology-oncology at Biruni University Hospital

Prof. Baytan specializes in childhood cancers with 15+ international articles published. He leads pediatric hematology at Emsey Hospital.

• Expert in leukemia, lymphoma, and childhood bleeding diseases
• Published 15 articles in international refereed journals
• Authored 3 books on pediatric hematology
• Specialized in anemia and vitamin deficiency treatments